CorMedix Signs 5-Year Agreement with ARC Dialysis to Supply DefenCath

Monday, 8 April 2024, 12:54

CorMedix has made a significant announcement regarding its 5-year supply contract with ARC Dialysis for DefenCath. The commercialization is set to start on April 15th, marking a strategic move in the medical industry. This partnership is expected to have a positive impact on both companies' market presence and growth in the coming years.

LivaRava Finance Meta Image — CorMedix Signs 5-Year Agreement with ARC Dialysis to Supply DefenCath

CorMedix Signs 5-Year Supply Contract with ARC Dialysis

CorMedix has entered into a 5-year agreement with ARC Dialysis for the supply of DefenCath, a key medical product in the industry. This collaboration is aimed at enhancing the availability of this essential product in the market.

Key Highlights:

Duration: 5-year agreement
Partners: CorMedix and ARC Dialysis
Product: DefenCath
Commercialization Date: April 15th

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.